Status:
ACTIVE_NOT_RECRUITING
PRecIsion Medicine in CardiomyopathY
Lead Sponsor:
The Hospital for Sick Children
Collaborating Sponsors:
Stanford University
Children's Hospital of Philadelphia
Conditions:
Hypertrophic Cardiomyopathy
Sudden Cardiac Death
Eligibility:
All Genders
Up to 18 years
Brief Summary
This is a retrospective cohort study of pediatric hypertrophic cardiomyopathy (HCM) patients using chart and registry review methodology. The studies objective is to develop and validate a sudden card...
Eligibility Criteria
Inclusion
- phenotype-positive patients diagnosed with hypertrophic cardiomyopathy
- phenotype-negative, genotype positive patients considered at risk for developing hypertrophic cardiomyopathy
Exclusion
- Neuromuscular, metabolic, syndromic (other than Noonan Syndrome and related RAS-opathies) or endocrine (including infants of diabetic mothers) causes of HCM
- (Other treatable causes of left ventricular hypertrophy (systemic hypertension, anatomic defects causing left ventricular outflow tract obstruction e.g. aortic stenosis, subAS, subaortic membrane, coarctation)
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
572 Patients enrolled
Trial Details
Trial ID
NCT04036799
Start Date
January 1 2017
End Date
December 1 2026
Last Update
May 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.